In vitro, MRPL13 silencing significantly inhibits the proliferation of breast cancer cells and changes the expression pattern of EMT-related genes by eliminating the positive contribution of AKT and mTOR phosphorylation [2]. This evidence concerns the gene MRPL13 and breast cancer.